VEGFA and cardiomyopathy: It has been discovered that heart conditions, such as coronary artery disease (CAD) and hypertension (HTA), which are two main risk factors for cardiomyopathy induced by VEGF inhibitors, had the same mechanism as inhibition of the VEGF pathway, underlining the importance of CAD and HTA as main risk factors [52].